MO | Jotup

Low-Dose Naltrexone in Gastroenterology: A Bonafide ‘Wonder Drug’

Retrieved on:

Friday, May 3, 2024

Defecation, Irritable bowel syndrome, Ulcerative colitis, Inflammation, Gastroenterology, Crohn's disease, RLS, Restless legs syndrome, Research, IBD, Inflammatory bowel disease, Flatulence, Psoriasis, Health, Immune system, LDN, IBS, Medical device

Dr. Weinstock's insightful piece sheds light on the potential of LDN as a novel therapeutic approach in the field of gastroenterology.

Key Points:

Dr. Weinstock's insightful piece sheds light on the potential of LDN as a novel therapeutic approach in the field of gastroenterology.
Low-dose naltrexone, traditionally known for its role in managing opioid and alcohol dependence, has emerged as a compelling option for addressing various gastrointestinal conditions.
Furthermore, Dr. Weinstock highlights the need for further research and clinical trials to fully elucidate LDN's therapeutic potential in gastroenterology.
For more information on Dr. Leonard Weinstock's insights into low-dose naltrexone in gastroenterology, please read his full article here .

Altria to Host Webcast of 2024 Annual Meeting of Shareholders

Retrieved on:

Thursday, May 2, 2024

Tobacco, Retail, Natural Resources, Wine & Spirits, Annual general meeting, Heated tobacco product, Conference, Environment

Altria Group, Inc. (Altria) (NYSE: MO) will host a live audio webcast of its 2024 Annual Meeting of Shareholders (“2024 Annual Meeting” or “meeting”) on Thursday, May 16, 2024 at 9:00 a.m. Eastern Time.

Key Points:

Altria Group, Inc. (Altria) (NYSE: MO) will host a live audio webcast of its 2024 Annual Meeting of Shareholders (“2024 Annual Meeting” or “meeting”) on Thursday, May 16, 2024 at 9:00 a.m. Eastern Time.
The 2024 Annual Meeting will be held virtually via live webcast.
During the meeting, shareholders as of the 2024 Annual Meeting record date (March 25, 2024) will be able to vote their shares electronically and will be able to submit questions during the meeting as time permits.
In lieu of a business update presentation at the 2024 Annual Meeting, we encourage shareholders and guests to review the resources listed below prior to the meeting.

All six physicians at Head & Neck Surgery of Kansas City are named 2024 Castle Connolly Top Doctors

Retrieved on:

Thursday, May 2, 2024

Ear, Nose, Castle Connolly Medical, Head, Patient, Audiology, Physician

OVERLAND PARK, Kan., May 2, 2024 /PRNewswire/ -- The six board-certified physicians at Head & Neck Surgery of Kansas City have been recognized by Castle Connolly as Top Doctors for 2024 .

Key Points:

OVERLAND PARK, Kan., May 2, 2024 /PRNewswire/ -- The six board-certified physicians at Head & Neck Surgery of Kansas City have been recognized by Castle Connolly as Top Doctors for 2024 .
Castle Connolly Top Doctors represent the top 7% of all U.S. practicing physicians.
Castle Connolly Top Doctors are peer-nominated and vetted by Castle Connolly's research team.
Head & Neck Surgery of Kansas City has been caring for ear, nose, throat, audiology and facial plastics patients for 30 years and has locations in Overland Park, KS, South Overland Park, KS and Grandview, MO.

Alcanza Strengthens Midwest Presence with Acquisition of Kansas City Research Institute

Retrieved on:

Wednesday, May 1, 2024

Hyperlipidemia, Acquisition, KCRI, Obesity, Health, Type 2 diabetes, Gastroenterology, Patient, Liver, DSM-IV codes, Nursing

ORLANDO, Fla., May 1, 2024 /PRNewswire/ -- Alcanza Clinical Research, a mission-focused investigator site network, announces the acquisition of Kansas City Research Institute (KCRI), a Phase II-IV clinical research site based in Kansas City, MO, with therapeutic specializations focused in gastroenterology, gastrointestinal oncology, hepatology, and a host of metabolic diseases (metabolic associated steatohepatitis [MASH], obesity, type 2 diabetes, hyperlipidemia).

Key Points:

ORLANDO, Fla., May 1, 2024 /PRNewswire/ -- Alcanza Clinical Research, a mission-focused investigator site network, announces the acquisition of Kansas City Research Institute (KCRI), a Phase II-IV clinical research site based in Kansas City, MO, with therapeutic specializations focused in gastroenterology, gastrointestinal oncology, hepatology, and a host of metabolic diseases (metabolic associated steatohepatitis [MASH], obesity, type 2 diabetes, hyperlipidemia).
"KCRI's specialty in liver and metabolic diseases, coupled with a track record of enrolling diverse patient populations strengthens the geographic and therapeutic breadth of the Alcanza site network."
"Joining Alcanza will ensure KCRI continues delivering on this commitment for the long-term future, as clinical research conduct increasingly requires sophisticated technology infrastructures, advanced operational management, and micro-targeted digital outreach.
We look forward to advancing the burgeoning research pipeline while providing the Kansas City metropolitan area with access to novel treatments."

THE CORDISH COMPANIES UNVEILS DETAILS FOR ITS LATEST LIVE! DESTINATION - LIVE! AT THE POINTE ORLANDO - OPENING THIS FALL IN ORLANDO, FLORIDA

Retrieved on:

Tuesday, April 30, 2024

ORLANDO, Fla., April 30, 2024 /PRNewswire/ -- The Cordish Companies announced today that their 73,000-square-foot dining and entertainment destination at Pointe Orlando will take on the Company's nationally acclaimed Live! hospitality and entertainment brand. LIVE! AT THE POINTE ORLANDO will bring an unmatched food and beverage, social, nightlife and special event experience to Orlando's tourism corridor when it opens this fall, creating a unique block party atmosphere for locals and tourists alike. Located on International Drive, Live! at The Pointe Orlando will be just a short drive from Orlando, Florida's major theme parks and across the street from the Orange County Convention Center. The Company also announced two new venues today for the project – HOUNDSMEN ENGLISH LOUNGE and SHARK BAR – joining previously announced anchor concepts SPORTS & SOCIAL and PBR COWBOY BAR. A major announcement of an additional two-level anchor concept will be happening within the next few weeks. Renderings can be downloaded here.

Key Points:

LIVE!
at The Pointe Orlando will be just a short drive from Orlando, Florida's major theme parks and across the street from the Orange County Convention Center.
"We are proud to continue working with Brixmor Property Group to bring a world-class experience to Pointe Orlando.
at The Pointe Orlando will offer options for small- and large-scale gatherings that can accommodate guest counts from 10 to over 4,000 people.

GLO30 Starts the Year Strong with 60% Growth

Retrieved on:

Tuesday, April 30, 2024

Primrose Schools, Foot, Microsoft, Beauty, Growth, Retail

WASHINGTON, April 30, 2024 /PRNewswire/ -- GLO30 – the nation's fastest-growing subscription-based skincare studio – started the year off at record speed with 60% growth. The brand announced the signing of six franchise agreements that will bring twenty-nine locations to five states – growing the brand's total units to 77 in development across 11 states.

Key Points:

"As we announce the remarkable growth of GLO30 in Q1, I am humbled by the extraordinary entrepreneurs who have chosen to partner with us in this exciting journey," said Dr. Arleen Lamba, founder of GLO30.
Their confidence in GLO30 fuels our determination to continue delivering unparalleled value and innovation in every aspect of our business."
GLO30 is targeting the top 50 MSAs in North America for franchise growth with an emphasis on areas with high foot traffic and a thriving community.
To see why GLO30 will reach 1,000 units in 10 years, prospective franchisees can visit fransmart.com/glo30 .

Passport's Digital Enforcement Solution Helps Cities Improve Payment Compliance and Recover Revenue

Retrieved on:

Monday, April 29, 2024

City, Weather, Congestion, Collection, Transport, Digital, Economic development, Pedestrian, LPR, GPS, Cryptocurrency

CHARLOTTE, N.C., April 29, 2024 /PRNewswire-PRWeb/ -- Passport, the leader in curb management solutions, is highlighting the growing demand for its Digital Enforcement Solution, which empowers cities to easily and effectively manage parking, make data-informed decisions, and maintain compliance. Passport's real-time enforcement technology software and integrated solution enable holistic parking management to provide cities with the ability to adapt to changing needs while driving compliance. In just the last 12 months, more than 20 cities nationwide have launched Passport enforcement, including Tampa, FL, Dallas, TX, Jackson, MS; and the City of Lebanon, OH, to include the spectrum of enforcement offerings from ticket issuance through collections.

Key Points:

Passport's real-time enforcement technology software and integrated solution enable holistic parking management to provide cities with the ability to adapt to changing needs while driving compliance.
"The reality is that the processes and technology underpinning parking enforcement are the backbone of an effective parking management program.
Ticket issuance and enforcement technology deliver critical data on parking behavior, occupancy rates, signage, communication efficacy, customer experience, and compliance trends.
With Passport's enforcement capabilities, the City of Clayton has seen a significant increase in parking compliance and punitive revenue recovery.

Post Holdings Reports Results for the Second Quarter of Fiscal Year 2024; Raises Fiscal Year 2024 Outlook

Retrieved on:

Thursday, May 2, 2024

Post, GAAP, Cheese, Investment, Nature, Safety, Pet food, Forecasting, Public expenditure, RTE, Senior, Foodservice, Share repurchase, Adjustment, Accounting, Interest, Pharmaceutical industry

For the second quarter, net sales were $1,065.5 million, an increase of 77.9%, or $466.4 million, compared to the prior year period.

Key Points:

For the second quarter, net sales were $1,065.5 million, an increase of 77.9%, or $466.4 million, compared to the prior year period.
For the second quarter, net sales were $138.0 million, an increase of 10.5%, or $13.1 million, compared to the prior year period.
For fiscal year 2024, Post management has raised its guidance range for Adjusted EBITDA to $1,335-$1,375 million from $1,290-$1,340 million.
ET to discuss financial results for the second quarter of fiscal year 2024 and fiscal year 2024 outlook and to respond to questions.

Aegion Rebrands as Azuria Water Solutions, Signaling a New Era in Water Infrastructure Solutions

Retrieved on:

Thursday, April 25, 2024

Water, Longevity

ST. LOUIS, April 25, 2024 (GLOBE NEWSWIRE) -- Aegion Corporation, a leading provider of pipeline rehabilitation and water solutions, today announced its official rebrand to Azuria TM Water Solutions .

Key Points:

ST. LOUIS, April 25, 2024 (GLOBE NEWSWIRE) -- Aegion Corporation, a leading provider of pipeline rehabilitation and water solutions, today announced its official rebrand to Azuria TM Water Solutions .
This significant change reflects the company's strategic focus on delivering technology-enabled solutions for the water infrastructure market.
"Azuria Water Solutions marks a new chapter for our company, and I am proud of our teams’ momentum during this transformation," said Rob Tullman, CEO of Azuria Water Solutions.
The new Azuria Water Solutions brand embodies the company's dedication to:
Innovation: Azuria Water Solutions is committed to developing cutting-edge technologies that improve the efficiency, longevity, and sustainability of water infrastructure.

H&R Block to Release Fiscal 2024 Third Quarter Results on May 9, 2024

Retrieved on:

Thursday, April 25, 2024

HRB, PIN, Webcast, H&R Block

KANSAS CITY, Mo., April 25, 2024 (GLOBE NEWSWIRE) -- H&R Block, Inc. (NYSE: HRB) will report fiscal 2024 third quarter results on Thursday, May 9, 2024, after the New York Stock Exchange market close.

Key Points:

KANSAS CITY, Mo., April 25, 2024 (GLOBE NEWSWIRE) -- H&R Block, Inc. (NYSE: HRB) will report fiscal 2024 third quarter results on Thursday, May 9, 2024, after the New York Stock Exchange market close.
At that time, a copy of the press release and presentation will be available on the company's investor relations website at https://investors.hrblock.com/ .
A conference call for analysts, institutional investors, and shareholders will be held at 4:30 p.m. Eastern time on Thursday, May 9, 2024.
During the conference call the company will discuss fiscal 2024 third quarter results, outlook, and give a general business update.